Brief: Abivax Announces Pricing For Nasdaq IPO

Abivax SA

20/10/2023 14:13

Oct 20 (Reuters) - Abivax SA  ABVX.PA :
    * ABIVAX ANNOUNCES THE PRICING OF ITS INITIAL PUBLIC
OFFERING ON
THE NASDAQ GLOBAL MARKET
    * INITIAL PUBLIC OFFERING ON NASDAQ GLOBAL MARKET BY WAY OF
A
CAPITAL INCREASE OF 20,325,500 NEW ORDINARY SHARES
    * OFFERING PRICE WAS SET AT $11.60 PER ADS IN U.S. OFFERING
    * CORRESPONDING OFFERING PRICE OF EUR 10.9864 PER ORDINARY
SHARE
BASED ON AN EXCHANGE RATE OF EUR 1.00 = $1.0559 AS PUBLISHED BY
EUROPEAN CENTRAL BANK ON OCTOBER 19, 2023
    * GLOBAL OFFERING IS EXPECTED TO CLOSE ON OCTOBER 24, 2023,
SUBJECT TO SATISFACTION OF CUSTOMARY CLOSING CONDITIONS
    * AGGREGATE GROSS PROCEEDS ARE EXPECTED TO BE APPROXIMATELY
$235.8
MILLION, EQUIVALENT TO APPROXIMATELY EUR 223.3 MILLION, BEFORE
DEDUCTION OF UNDERWRITING COMMISSIONS AND ESTIMATED EXPENSES

Source text for Eikon:  ID:nEQ1LH15la 
Further company coverage:  ABVX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))